Global Implantable Drug Eluting Balloon Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Implantable Drug Eluting Balloon market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Implantable Drug Eluting Balloon is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Implantable Drug Eluting Balloon is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Implantable Drug Eluting Balloon is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Implantable Drug Eluting Balloon is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Implantable Drug Eluting Balloon include Yinyi Biotech, Medtronic, Philips, Boston Scientific, B. Braun, Eurocor, BD, Aachen Resonance and Biotronic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Implantable Drug Eluting Balloon, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Implantable Drug Eluting Balloon, also provides the sales of main regions and countries. Of the upcoming market potential for Implantable Drug Eluting Balloon, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Implantable Drug Eluting Balloon sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Implantable Drug Eluting Balloon market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Implantable Drug Eluting Balloon sales, projected growth trends, production technology, application and end-user industry.

Implantable Drug Eluting Balloon Segment by Company

Yinyi Biotech
Medtronic
Philips
Boston Scientific
B. Braun
Eurocor
BD
Aachen Resonance
Biotronic
Implantable Drug Eluting Balloon Segment by Type

Peripheral DEBs
Coronary DEBs
Implantable Drug Eluting Balloon Segment by Application

Catheterization Laboratory
Hospital
Other
Implantable Drug Eluting Balloon Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Drug Eluting Balloon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Implantable Drug Eluting Balloon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Drug Eluting Balloon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Implantable Drug Eluting Balloon market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Implantable Drug Eluting Balloon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Implantable Drug Eluting Balloon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Implantable Drug Eluting Balloon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Implantable Drug Eluting Balloon Market Size, 2020 VS 2024 VS 2031
1.3 Global Implantable Drug Eluting Balloon Market Size Estimates and Forecasts (2020-2031)
1.4 Global Implantable Drug Eluting Balloon Sales Estimates and Forecasts (2020-2031)
1.5 Global Implantable Drug Eluting Balloon Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Implantable Drug Eluting Balloon Market Dynamics
2.1 Implantable Drug Eluting Balloon Industry Trends
2.2 Implantable Drug Eluting Balloon Industry Drivers
2.3 Implantable Drug Eluting Balloon Industry Opportunities and Challenges
2.4 Implantable Drug Eluting Balloon Industry Restraints
3 Implantable Drug Eluting Balloon Market by Manufacturers
3.1 Global Implantable Drug Eluting Balloon Revenue by Manufacturers (2020-2025)
3.2 Global Implantable Drug Eluting Balloon Sales by Manufacturers (2020-2025)
3.3 Global Implantable Drug Eluting Balloon Average Sales Price by Manufacturers (2020-2025)
3.4 Global Implantable Drug Eluting Balloon Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Implantable Drug Eluting Balloon Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Implantable Drug Eluting Balloon Manufacturers, Product Type & Application
3.7 Global Implantable Drug Eluting Balloon Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Implantable Drug Eluting Balloon Market CR5 and HHI
3.8.2 Global Top 5 and 10 Implantable Drug Eluting Balloon Players Market Share by Revenue in 2024
3.8.3 2024 Implantable Drug Eluting Balloon Tier 1, Tier 2, and Tier 3
4 Implantable Drug Eluting Balloon Market by Type
4.1 Implantable Drug Eluting Balloon Type Introduction
4.1.1 Peripheral DEBs
4.1.2 Coronary DEBs
4.2 Global Implantable Drug Eluting Balloon Sales by Type
4.2.1 Global Implantable Drug Eluting Balloon Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Implantable Drug Eluting Balloon Sales by Type (2020-2031)
4.2.3 Global Implantable Drug Eluting Balloon Sales Market Share by Type (2020-2031)
4.3 Global Implantable Drug Eluting Balloon Revenue by Type
4.3.1 Global Implantable Drug Eluting Balloon Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Implantable Drug Eluting Balloon Revenue by Type (2020-2031)
4.3.3 Global Implantable Drug Eluting Balloon Revenue Market Share by Type (2020-2031)
5 Implantable Drug Eluting Balloon Market by Application
5.1 Implantable Drug Eluting Balloon Application Introduction
5.1.1 Catheterization Laboratory
5.1.2 Hospital
5.1.3 Other
5.2 Global Implantable Drug Eluting Balloon Sales by Application
5.2.1 Global Implantable Drug Eluting Balloon Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Implantable Drug Eluting Balloon Sales by Application (2020-2031)
5.2.3 Global Implantable Drug Eluting Balloon Sales Market Share by Application (2020-2031)
5.3 Global Implantable Drug Eluting Balloon Revenue by Application
5.3.1 Global Implantable Drug Eluting Balloon Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Implantable Drug Eluting Balloon Revenue by Application (2020-2031)
5.3.3 Global Implantable Drug Eluting Balloon Revenue Market Share by Application (2020-2031)
6 Global Implantable Drug Eluting Balloon Sales by Region
6.1 Global Implantable Drug Eluting Balloon Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Implantable Drug Eluting Balloon Sales by Region (2020-2031)
6.2.1 Global Implantable Drug Eluting Balloon Sales by Region (2020-2025)
6.2.2 Global Implantable Drug Eluting Balloon Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Implantable Drug Eluting Balloon Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Implantable Drug Eluting Balloon Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Implantable Drug Eluting Balloon Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Implantable Drug Eluting Balloon Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Implantable Drug Eluting Balloon Revenue by Region
7.1 Global Implantable Drug Eluting Balloon Revenue by Region
7.1.1 Global Implantable Drug Eluting Balloon Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Implantable Drug Eluting Balloon Revenue by Region (2020-2025)
7.1.3 Global Implantable Drug Eluting Balloon Revenue by Region (2026-2031)
7.1.4 Global Implantable Drug Eluting Balloon Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Implantable Drug Eluting Balloon Revenue (2020-2031)
7.2.2 North America Implantable Drug Eluting Balloon Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Implantable Drug Eluting Balloon Revenue (2020-2031)
7.3.2 Europe Implantable Drug Eluting Balloon Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Implantable Drug Eluting Balloon Revenue (2020-2031)
7.4.2 Asia-Pacific Implantable Drug Eluting Balloon Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Implantable Drug Eluting Balloon Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Implantable Drug Eluting Balloon Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Yinyi Biotech
8.1.1 Yinyi Biotech Comapny Information
8.1.2 Yinyi Biotech Business Overview
8.1.3 Yinyi Biotech Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Yinyi Biotech Implantable Drug Eluting Balloon Product Portfolio
8.1.5 Yinyi Biotech Recent Developments
8.2 Medtronic
8.2.1 Medtronic Comapny Information
8.2.2 Medtronic Business Overview
8.2.3 Medtronic Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Medtronic Implantable Drug Eluting Balloon Product Portfolio
8.2.5 Medtronic Recent Developments
8.3 Philips
8.3.1 Philips Comapny Information
8.3.2 Philips Business Overview
8.3.3 Philips Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Philips Implantable Drug Eluting Balloon Product Portfolio
8.3.5 Philips Recent Developments
8.4 Boston Scientific
8.4.1 Boston Scientific Comapny Information
8.4.2 Boston Scientific Business Overview
8.4.3 Boston Scientific Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Boston Scientific Implantable Drug Eluting Balloon Product Portfolio
8.4.5 Boston Scientific Recent Developments
8.5 B. Braun
8.5.1 B. Braun Comapny Information
8.5.2 B. Braun Business Overview
8.5.3 B. Braun Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 B. Braun Implantable Drug Eluting Balloon Product Portfolio
8.5.5 B. Braun Recent Developments
8.6 Eurocor
8.6.1 Eurocor Comapny Information
8.6.2 Eurocor Business Overview
8.6.3 Eurocor Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Eurocor Implantable Drug Eluting Balloon Product Portfolio
8.6.5 Eurocor Recent Developments
8.7 BD
8.7.1 BD Comapny Information
8.7.2 BD Business Overview
8.7.3 BD Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 BD Implantable Drug Eluting Balloon Product Portfolio
8.7.5 BD Recent Developments
8.8 Aachen Resonance
8.8.1 Aachen Resonance Comapny Information
8.8.2 Aachen Resonance Business Overview
8.8.3 Aachen Resonance Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Aachen Resonance Implantable Drug Eluting Balloon Product Portfolio
8.8.5 Aachen Resonance Recent Developments
8.9 Biotronic
8.9.1 Biotronic Comapny Information
8.9.2 Biotronic Business Overview
8.9.3 Biotronic Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Biotronic Implantable Drug Eluting Balloon Product Portfolio
8.9.5 Biotronic Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Implantable Drug Eluting Balloon Value Chain Analysis
9.1.1 Implantable Drug Eluting Balloon Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Implantable Drug Eluting Balloon Production Mode & Process
9.2 Implantable Drug Eluting Balloon Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Implantable Drug Eluting Balloon Distributors
9.2.3 Implantable Drug Eluting Balloon Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings